About Philip Ball
Philip Ball is SVP, Head of Business Development and Operations, director at Tolerance Bio.
Experience
This experience comes from Philip Ball's profile and from SEC filings. For roles taken from filings, the years are when the filings name Philip Ball in the role, so the role may have started earlier or lasted longer.
Tolerance Bio Inc. Current
SVP, Head of Business Development and Operations, director
Chief Business Officer (2023 – Present)
2023 – Present · Philadelphia, PA
Develops thymus-based therapies for people with immune-mediated diseases.
PS
Provention Bio (now Sanofi)
Vice President, Alliance Management and Business Development
2021 – 2023
IN
Innopiphany
Principal, Head of Policy Practice
2020 – 2021
AL
Allergan
Executive Director, U.S. Value Policy and Strategy (2015 – 2020)
Technical Director, USA (2006 – 2012)
2006 – 2020
AA
Actavis plc (now Allergan)
Director, Biologics Alliance Management and Government Affairs
2012 – 2015
EB
Eden Biodesign
Analytical and Purification Development Manager
2005 – 2009
EB
Eden Biopharm
Biopharmaceutical Development Consultant
2003 – 2005
Key Colleagues at Startups
The people Philip Ball works with at each company, as listed on that company's latest Form D.
Tolerance Bio Inc. · Form D, Jun 18, 2026
DC
Damia Carulla
Director
Justin Vogel
Chief Financial Officer and director
Francisco Leon
Founder and CEO, director
PC
Pablo Cironi
Director
RG
Robert Goldstein
Director